Description
Pavunalimab Biosimilar - Anti-LAG3/CTLA4 mAb - Research Grade
Target
LAG3/CTLA4
Target Alias Name
Pavunalimab/ANTI-CTLA-4/LAG-3 BISPECIFIC ANTIBODY XMAB22841/ IMMUNOGLOBULIN HALF-IG G1-KAPPA/SCFV-H-CH2-CH3/ ANTI-(HOMO SAPIENS LAG3 (LYMPHOCYTE ACTIVATING 3/ LYMPHOCYTE-ACTIVATION 3/ CD223)) AND ANTI-(HOMO SAPIENS CTLA4 (CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4/ CD152))/ MONOCLONAL ANTIBODY/ BISPECIFIC/ XMAB-22841/LAG3/CTLA4/anti-LAG3/CTLA4
Isotype/Mimetic
Bispecific /IgG1/Kappa
Animal-Derived Biomaterials Used
None
Sequence Available
No
Original Discovery Method
Unknown
Original Discovery Information Provided On Datasheet
No
Antibody/Binder Origins
Unknown discovery source/method, In vitro recombinant expression